These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 4136749)
1. Genitourinary-tract problems of the aged male. Basso A J Am Geriatr Soc; 1974 Aug; 22(8):352-4. PubMed ID: 4136749 [No Abstract] [Full Text] [Related]
2. The EORTC Phase III trials in prostatic cancer. Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132 [No Abstract] [Full Text] [Related]
3. [Predictive value of clinical, biochemical, hormonal and histologic parameters of the endocrine response in prostatic adenocarcinoma]. Burgos FJ; Maganto E; Jiménez M; Mayayo T; Allona A; Mateos A; Escudero A; Romero-Aguirre C Actas Urol Esp; 1988; 12(6):500-6. PubMed ID: 3232555 [No Abstract] [Full Text] [Related]
4. Adenocarcinoma of the prostate. Von Eschenbach AC; Johnson DE Compr Ther; 1978 Aug; 4(8):18-26. PubMed ID: 688739 [No Abstract] [Full Text] [Related]
5. Current concepts concerning carcinoma of the prostate. Skinner DG Surg Annu; 1973; 5():393-406. PubMed ID: 4602222 [No Abstract] [Full Text] [Related]
6. Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging. Gleason DF; Mellinger GT; J Urol; 2017 Feb; 197(2S):S134-S139. PubMed ID: 28012760 [No Abstract] [Full Text] [Related]
7. Prostatic cancer with bone marrow involvement and long-term survival: association with intravenous chemotherapy. Boatman DL; Nelson CM; Flocks RH; Schmidt JD J Surg Oncol; 1973 May; 5(5):481-4. PubMed ID: 4752465 [No Abstract] [Full Text] [Related]
8. EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate. Robinson MR Prog Clin Biol Res; 1988; 260():101-10. PubMed ID: 2966402 [No Abstract] [Full Text] [Related]
10. An unusual remission of prostatic carcinoma with pulmonary metastases. Stenberg CC; Bunts RC J Urol; 1969 Aug; 102(2):236-9. PubMed ID: 5796902 [No Abstract] [Full Text] [Related]
11. Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials. de Voogt HJ; Suciu S; Sylvester R; Pavone-Macaluso M; Smith PH; de Pauw M J Urol; 1989 Apr; 141(4):883-8. PubMed ID: 2522561 [TBL] [Abstract][Full Text] [Related]
12. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. Gleason DF; Mellinger GT J Urol; 1974 Jan; 111(1):58-64. PubMed ID: 4813554 [No Abstract] [Full Text] [Related]
14. Further experience with the Franzen transrectal prostatic biopsy needle. Ward JP Ann Chir Gynaecol Fenn; 1974; 63(1):48-52. PubMed ID: 4134053 [No Abstract] [Full Text] [Related]
15. Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate. Robinson MR Prog Clin Biol Res; 1987; 243A():383-90. PubMed ID: 2958863 [No Abstract] [Full Text] [Related]